Physician profile
Christopher S West
NPI 1588735310
$245,896.55
in general payments reported to CMS, 2019-2025
38 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $4,141 · 2021: $6,007 · 2022: $63K · 2023: $58K · 2024: $40K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119K · Consulting Fee: $41K · Food and Beverage: $5,967 · Travel and Lodging: $4,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $119,446.89 |
| Consulting Fee | $41,468.75 |
| Food and Beverage | $5,966.81 |
| Travel and Lodging | $4,783.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $237,982.09 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $3,308.36 | 2019-2025 | Lumenis Pulse 120h, Greenlight Xps, Rezum Generator |
| Neotract INC. | $1,253.87 | 2019-2020 | |
| Karl Storz Endoscopy-America | $420.70 | 2019-2021 | |
| Astellas Pharma US INC | $407.43 | 2019-2023 | Myrbetriq |
| Calyxo, INC. | $359.44 | 2023-2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $339.08 | 2021-2024 | Prolaris |
| Procept Biorobotics Corporation | $325.07 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $190.19 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $144.04 | 2021-2023 | Jelmyto |
| Axonics, INC. | $114.75 | 2023 | Axonics |
| Medtronic, INC. | $110.22 | 2025 | |
| Antares Pharma, INC. | $100.22 | 2019-2023 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $98.72 | 2023-2025 | Speedicath |
| Insmed, INC. | $81.70 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $80.39 | 2021-2023 | Oxlumo |
| Merck Sharp & Dohme LLC | $59.46 | 2025 | Keytruda |
| Tolmar, INC. | $53.78 | 2023 | |
| Olympus America INC. | $41.87 | 2021-2023 | Soltive, Itind System |
| Cook Medical LLC | $34.10 | 2019-2024 | Resonance |
| Palette Life Sciences, INC. | $33.79 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $32.72 | 2019-2022 | |
| Convatec INC. | $29.71 | 2025 | |
| Progenics Pharmaceuticals, INC. | $29.30 | 2025 | |
| Verity Pharmaceuticals INC. | $29.13 | 2025 | Tlando |
| Tolmar Pharmaceuticals, INC. | $25.88 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $24.22 | 2025 | Adstiladrin |
| Avadel Specialty Pharmaceuticals, LLC | $23.75 | 2019 | |
| Biocompatibles, INC. | $23.43 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $21.69 | 2021 | |
| Metuchen Pharmaceuticals | $16.48 | 2019 | |
| Blue Earth Diagnostics | $16.03 | 2021 | |
| Urovant Sciences INC | $15.98 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.81 | 2021 | |
| Innovation Technologies INC | $14.55 | 2025 | Irrisept |
| Janssen Biotech, INC. | $13.98 | 2019 | |
| Allergan, INC. | $12.47 | 2019 | |
| Endo Pharmaceuticals INC. | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.